Suchergebnisse - "Godwin, Kerry"

PubPharm (14)

1

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines

enthalten in: Vaccine | 2023

von Dold, C. | Zhu, H. | Silva-Reyes, L. | +9

2

Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge

enthalten in: bioRxiv.org | 2021

von Ryan, K. | Bewley, K. | Fotheringham, S. | +46

3

Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19

enthalten in: bioRxiv.org | 2021

von Salguero, F. | White, A. | Slack, G. | +55

4

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

enthalten in: Nature medicine | 2021

von Feng, S. | Phillips, D. | White, T. | +96

5

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV) : a single-blind, randomised, non-inferiority trial

enthalten in: Lancet (London, England) | 2021

von Liu, X. | Shaw, R. | Stuart, A. | +86

CommentIn: Lancet. 2021 Sep 4;398(10303):819-821. - PMID 34370969

6

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays

enthalten in: Nature protocols | 2021

von Bewley, K. | Coombes, N. | Gagnon, L. | +19

7

Author Correction : Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

enthalten in: Nature medicine | 2021

von Barrett, J. | Belij-Rammerstorfer, S. | Dold, C. | +152

ErratumFor: Nat Med. 2021 Feb;27(2):279-288. - PMID 33335322

8

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

enthalten in: Cell | 2021

von Supasa, P. | Zhou, D. | Dejnirattisai, W. | +50

CommentIn: Signal Transduct Target Ther. 2021 Apr 10;6(1):151. - PMID 33839737

9

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

enthalten in: Nature communications | 2021

von Salguero, F. | White, A. | Slack, G. | +61

10

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

enthalten in: Nature medicine | 2021

von Barrett, J. | Belij-Rammerstorfer, S. | Dold, C. | +152

CommentIn: Nat Rev Immunol. 2021 Feb;21(2):70-71. - PMID 33432129